Sunshine Biopharma Inc. (NASDAQ: SBFM)
$0.32
-0.0132 ( -3.91% ) 593.4K
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
Market Data
Open
$0.32
Previous close
$0.34
Volume
593.4K
Market cap
$6.18M
Day range
$0.32 - $0.35
52 week range
$0.28 - $64.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
pre | Proxies and info statements | 1 | Feb 21, 2024 |
8-k | 8K-related | 15 | Feb 16, 2024 |
8-k | 8K-related | 20 | Feb 15, 2024 |
4 | Insider transactions | 1 | Feb 12, 2024 |
8-k | 8K-related | 17 | Feb 12, 2024 |
3 | Insider transactions | 1 | Feb 09, 2024 |
8-k | 8K-related | 15 | Jan 30, 2024 |
8-k | 8K-related | 13 | Dec 07, 2023 |
8-k | 8K-related | 15 | Nov 13, 2023 |
10-q | Quarterly Reports | 59 | Nov 13, 2023 |